Coronavirus disease 2019 (COVID-19): first indication of efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 infection.

Polansky, Hanan; Lori, Gillad

Polansky, Hanan; Lori, Gillad.

Polansky H; The Center for the Biology of Chronic Disease (CBCD), 616 Corporate Way, Suite 2-3665, Valley Cottage, NY 10989, USA. Electronic address: hpolansky@cbcd.net.
Lori G; The Center for the Biology of Chronic Disease (CBCD), 616 Corporate Way, Suite 2-3665, Valley Cottage, NY 10989, USA.

Int J Antimicrob Agents ; 55(6): 105971, 2020 Jun.

Article in English | MEDLINE | ID: covidwho-143399

Subject(s)

Antiviral Agents/pharmacology; Betacoronavirus/drug effects; Coronavirus Infections/drug therapy; Plant Extracts/pharmacology; Pneumonia, Viral/drug therapy; Quercetin/pharmacology; Selenium/pharmacology; COVID-19; Drug Combinations; Humans; Pandemics; SARS-CoV-2; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Quercetin / Selenium / Plant Extracts / Coronavirus Infections / Betacoronavirus Limits: Humans Language: English Journal: Int J Antimicrob Agents Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google